As part of our ongoing aim to bring you reports of innovative developments, we have added a review of a recent exploration of current unresolved questions in treatment-naïve chronic lymphocytic leukaemia.
Independent commentary is provided by Professor Stephen Opat, a clinical haematologist, research lead CLL/indolent lymphoma, and cancer program director at Monash Health.
Please login below to download this issue (PDF)